Cable Car Capital »

Gain Therapeutics shares owned by Cable Car Capital

Quarter-by-quarter ownership of Gain Therapeutics (GANX) shares owned by Cable Car Capital from 13F filings

Historical chart of Cable Car Capital investment in Gain Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Gain Therapeutics held by Cable Car Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Gain Therapeutics by Cable Car Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $186k 145k 1.28

More positions owned by Cable Car Capital

Arca Biopharma (ABIO)
Melar Acquisition Corp. I Unit 06/10/2029 (MACIU)
Pangaea Logistics Solution L SHS (PANL)
McGrath Rent (MGRC)
Cornerstone Total Rtrn Fd In (CRF)
Cornerstone Strategic Value (CLM)
Synlogic Com New (SYBX)
Perception Capital Corp Iii Class A Ord Shs (PFTA)
Welsbach Tech Metals Acqu (WTMA)
Dt Cloud Acquisition Corp Unit 99/99/9999 (DYCQU)
Chenghe Acquisition Ii Unit 05/30/2031 (CHEB.U)
Instil Bio Com New (TIL)
Aimfinity Investment Corp I Unit 04/21/2027 (AIMBU)
Perception Capital Corp Iv Cl A Com (RCFA)
Gee Group (JOB)

View all positions for Cable Car Capital

Top funds holding Gain Therapeutics

DME Capital Management
Gotham Asset Management
Hohimer Wealth Management
Geode Capital Management
Vanguard Group
Cable Car Capital
BlackRock
BlackRock
Jones Financial Companies, L.L
Renaissance Technologies
Northern Trust
Bridgeway Capital Management
State Street Corporation
Virtu Financial
Susquehanna International

View all funds holding Gain Therapeutics